ODLUMIVIE Peptide CalmMist

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
ODLUMIVIE Peptide CalmMist
Generic name
PALMITOYL TRIPEPTIDE-8
Manufacturer
ODLUMIVIE
Product type
HUMAN OTC DRUG
SPL set ID
435e6717-5fbf-5cb2-e063-6294a90a40d7
SPL ID
435e673e-6e45-e79b-e063-6394a90a3298
Version
26
Effective date
2025-11-11
Source export date
2026-08-08
Source partition
2
Source file
https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-08-08/c371bcf53af83126908f941c4bb6f83aeaa6e2ef3749f9f7be6c7a3681e3b333/drug-label-0002-of-0014.json.zip
Source manifest SHA-256
b39f3b00ad50d2e1b32aaf429248c6081e8799b35bce715b4fccb8cfa1ac4546
Import run
20260810T161303Z
Imported at
2026-08-10 16:21:41
Harmonized routes table
Harmonized routes
CUTANEOUS

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

CAUTION For external use only. Avoid directcontact with eyes. Ifirritation occurs, stop useand consult a doctor if needed.Patch test recommended.Do not use if you are allergic to any of theingredients.Keep out of reach of children.